SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-004177
Filing Date
2023-02-23
Accepted
2023-02-23 17:21:05
Documents
12
Period of Report
2023-02-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gern-20230221.htm   iXBRL 8-K 61320
  Complete submission text file 0000950170-23-004177.txt   239105

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20230221.xsd EX-101.SCH 2561
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20230221_lab.xml EX-101.LAB 32471
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20230221_pre.xml EX-101.PRE 26218
6 EXTRACTED XBRL INSTANCE DOCUMENT gern-20230221_htm.xml XML 4700
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 23661083
SIC: 2834 Pharmaceutical Preparations